Optiva® LS Prime reduces formulators and bakers’ dependency on added sugar without compromising sweetness. The innovation hits the sweet spot between quality and cost, helping bakers improve profit margins while delivering the same high caliber of baked goods. COPENHAGEN, Denmark – June 11, 2025. Worldwide, bakers are facing historically low margins due to rising raw material costs, including for one essential ingredient: sugar. Since 2019, sugar prices have soared by more than 50%, leaving the baking industry challenged. As a result, formulators and bakers are left with the options to change their recipe, and compromise on quality – or ultimately, have consumers pay the price. With Optiva® LS Prime from Novonesis, a global leader in biosolutions, formulators can help bakers reduce the amount of sugar in their formulation and still achieve the same sweetness level, making them less dependent on the crucial ingredient. Optiva® LS works by converting starch into sugar, resulting in improved sweetness with less added sugar, without compromising taste or quality. Same high quality and better margins Cost and quality are top of mind for nearly half of consumers when choosing bread, while 72% of consumers remain concerned about increasing everyday costs. Optiva® LS Prime can help formulators manage their customers’ volatile raw material prices, improve their margins – and according to sensory tests – achieve the same high sensory quality that consumers expect. “With the ongoing increase and fluctuations in raw material costs and consumers expecting affordable baked goods with high sensory quality, bakers are facing tough decisions. With Optiva® LS Prime, we’re introducing a breakthrough solution that helps reduce reliance on sugar without sacrificing sweetness or quality. This innovation not only creates a robust bottom line for bakeries but also meets the growing demand for high quality baked goods”, says Adam Benjamin Vestergaard Diggle, Head of Baking. Contact usFor more information, please contact our media relations colleagues by reaching out to our shared e-mail: media-relations@novozymes.com
